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Abstract
Polymeric networks that retain and absorb substantial amount of water or biological 
fluids and resemble as a biological tissue are defined as hydrogels. On the other hand, 
liposomes, transfersomes and niosomes are lipid carriers, which represent one of the 
major research and development focus areas of the pharmaceutical industry. They have 
great potential as lipid vehicles that are able to enhance permeation of drugs across the 
intact skin and can act as local depot for the drug to sustain and control its delivery. Lipid 
carrier and hydrogel combinations offer transdermal drug delivery of great potential to 
enhance systemic effects of both hydrophilic and lipophilic drugs. Also, lipid carriers 
can target drugs to skin appendages and improve transdermal delivery. Lipid carrier 
proform systems in the form of gelly liquid crystals can also be used transdermally for 
better drug absorption enhancement. This review highlights the potential of hydrogels 
and emulgels with or without lipid nanocarriers for dermal and transdermal application.
Keywords: hydrogel, emulgel, liposome, niosome, transfersomes
1. Introduction
Lipid carriers such as liposomes, niosomes, and transferesomes can be brought into gel for‐
mulations either in their proforms or in hydrogel vehicles and applied transdermally. They 
offer the capability of controlling drug release, enhancing drug transdermal absorption and 
increasing drug bioavailability compared to the plain gels [1]. Pharmaceutical gel prepara‐
tions such as hydrogels, organogels, and emulgels have been extensively used to deliver both 
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hydrophilic and lipophilic drugs for dermatological and transdermal use. Gels are cross‐
linked assembly containing both solid and liquid components within its configuration, which 
were considered as gelling agents and called gelators [2]. When the gelators are dispersed 
in appropriate solvent, they were associated together forming network of three‐dimensional 
structure, which immobilize the surrounding aqueous media [2]. These results are followed 
by a series of the interactions to form the polymeric cross‐linked network structures, which 
retained certain amount of the water [3]. The synthetic or natural gelators have ability to form 
this series of interactions producing macromolecular chain reaction. It was declared that the 
hydrophilic groups of the polymers build up gel like structure upon the hydration in the 
liquid environment. The gelation process stated that the polymer chains connected together 
to form large branched soluble polymers, which are called ‘sol’. Afterward, the aggregation 
process leads to an increase in the branched polymer length with decreasing of the solubility 
of the polymers. This macrobranched polymer is called “gel”. Then the gelation effect is called 
‘sol‐gel transition’ and the gel point is defined as the first point of gel formation [4]. Therefore, 
it is recognized that the ideal gels were developed following the incorporation of gelator 
molecules and the proper liquid phase resultant of self aggregation in the environmental 
medium. Thus, the gels were formed because of physical and chemical interaction between 
polymers chains. These interactions might form irreversible or reversible links producing 
permanent or temporary bonds. Hydrogen bonding, van der Waals force, hydrophobic inter‐
actions, ð‐ð interactions, lamellar microcrystals, glassy nodules or double and triple helices 
blocks copolymer micelles and ionic associations are the physical interactions included in 
hydrogel formulations [5].
Hydrogels are polymeric networks, which can absorb and retain substantial amount of water 
or biological fluids within their porous structure. Several natural and synthetic polymers 
either solely or cross‐linked are used in formulating hydrogels. Crosslinking of polymers pro‐
vides high physical integrity to the network structure as well as to control the release of drug 
molecules. Newer ligands and different types of crosslinking allow the development of ideal 
hydrogel systems with appropriate release characteristics for the successful delivery of drugs, 
such as nucleic acids, proteins and peptides. The hydrogels have extended their applications 
in targeted drug delivery and as constituents for preparation of protein or enzyme conju‐
gates. Also, the chemical process may involve a range of interactions such as: formation of 
covalent bonds always resulting in a strong gel. The three main chemical gelation processes 
were noticed: (1) condensation, (2) vulcanization, and (3) addition polymerization [5]. These 
types of bonds have great important roles in the controlling of the physical and chemical char‐
acterizations, properties, and structure of the gels. The key for the classification of gels into 
organogel or hydrogel was based on the type of solvent, polymer used, and polymer chain 
interactions. If the solvent is organic in nature, then the gel is considered as organogel, else 
hydrogel [6]. On the other hand, emulgel is a semisolid vehicle that is composed of hydro‐
philic surfactant (s), oil, water, and gelling agent, “an emulsion transformed to a gel by gelling 
agent” [7]. Emulgel bases offer the advantage that of being capable of incorporating aqueous 
and oleaginous ingredients, and their rheological properties can be controlled easily.
The focus of the current chapter in gel drug delivery with or without a carrier system is to 
increase the range of products, which can effectively deliver the drug with specific release 
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characteristics. The properties of certain gels to undergo sharp volume or sol‐gel phase tran‐
sition in specific environment have provided their importance in drug delivery with new 
promising applications. Progresses in polymer chemistry and gel technology have extended 
the prospective of gels in transdermal drug delivery.
2. Hydrogels and lipid carriers for drug delivery
2.1. Hydrogels
Hydrogels offer several favorable characteristics, which are crucial for designing suit‐
able drug delivery systems. Typically, they are polymeric matrices, which are capable of 
imbibing greater amount of water, due to the good thermodynamic compatability which 
allow them to swell to a higher extent. These hydrogels emerged as a promising option 
for drug delivery scientists mainly due to their significant physicochemical and biological 
properties such as reversible swelling and shrinking, good sorption capacity, mechanical 
strength, considerable biocompatibility, desired drug release, tissue like physical proper‐
ties, accommodating wide range of molecules, better compatibility, easy to fabricate, good 
oxygen permeability, low interfacial tension, nontoxic, etc. In addition, they offer several 
other characteristics like bioadhesion, mucoadhesion, rapid deformation, ease of surface 
modification, conforming the shape of surface which they are applied, which make them 
ideal for drug delivery vehicles for targeted drug delivery [8]. However, the physical prop‐
erties of hydrogels are usually influenced by the charge of polymer, molecular weight of 
polymer, density of crosslinking, etc.
The biocompatibility of hydrogels is primarily owing to their higher water content and 
physicochemical similarity to the native extracellular matrix. They resemble more biologi‐
cal tissues probably due to their high water content, soft consistency and three‐dimensional 
polymeric network. Indeed, the existence of three‐dimensional structure of hydrogels could 
be employed in the design and development of different drug delivery systems. Moreover, 
the rubbery nature will minimize the mechanical irritation of the polymer to the surround‐
ing body tissues. Further, hydrogels are highly compatible with most of the drugs, proteins 
and peptides. They can be modified and fabricated into desired formulations of specific size 
or shape. Thus, hydrogels appeared to be the ideal vehicle for dermal as well as transdermal 
delivery and different transdermal formulations like matrix patch, reservoir system, gel and 
carrier system. On the other hand, there are some few limitations, which confine the applica‐
tions of hydrogels in drug delivery such as relatively low tensile strength, nonuniformity in 
drug loading of hydrophobic drugs and rapid drug release [9].
2.2. Lipid carriers
Lipid carriers such as liposomes, niosomes, and transfersomes have many applications 
expanded from conventional drugs to hormones, peptides, immunoglobulin, vaccination, and 
gene therapy. These drug delivery carriers employ different rate‐controlling mechanisms such 
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as membrane diffusion, diffusion through matrices, osmosis and biodegradation. An explosion 
in research in drug delivery by nonconventional routes such as transdermal, nasal, ocular, pul‐
monary, and intraarterial routes has been reported.
2.2.1. Liposomes/niosomes and their pro‐forms
Liposomes are the microscopic spherical phospholipids vesicles that form spontaneously 
when mixed in water under low shear conditions [10]. The phospholipid molecules arranged 
in layers or sheets and the molecules aligned side by side, in which the hydrophilic heads 
of phospholipid and their hydrophobic tails down. These phospholipid layers then formed 
bilayer membranes that encapsulate some of the aqueous vehicles inside a lipid sphere 
(Figure 1).
Liposomes are structurally related to cell membrane “phospholipid bilayer” and have been 
used in the study of biological membranes instead of using cadaver skin of human [11]. 
Moreover, liposomes as lipid carriers have been extensively evaluated as delivery vehicles 
for drugs, genes and/or cosmetics [12]. Liposomes undergo the problem of both chemical and 
physical instability; hence, the concept of proliposomes was introduced [13]. Proliposomes 
with least or no water content were prepared in three different forms: dry free‐flowing granu‐
lar product, mixed micellar proliposomes, and liquid crystalline proliposomes for reconstitu‐
tion immediately at time of use (Figure 2). The proliposome liquid crystal type formulae were 
used successfully for transdermal drug delivery [14].
On the other hand, niosomes are nonionic surfactant vesicles of multilamellar or unilamel‐
lar bilayer membrane structures such as liposomes. They can encapsulate both hydrophilic 
Figure 1. Schematic representation of lipid carriers “liposomes, niosomes, and transfersomes” structure and composition.
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and hydrophobic molecules in the aqueous compartment and in the bilayer lipid membrane, 
respectively [15]. These niosomes are chemically stable, and no special conditions are required 
while preparation or storage, such as nitrogen atmosphere or low temperature. Niosomes are 
inexpensive alternatives of nonbiological origin to liposomes which are widely studied in 
vivo [16]. Moreover, they are extensively used as lipid carrier similar to liposomes physi‐
cally, with particular properties, which can be exploited to attain different release character‐
istics and drug distributions [16]. Preliminary studies indicated that niosomes could prolong 
the plasma circulation of an entrapped drug and alter its distribution pattern and its meta‐
bolic stability [17]. Also, niosomal systems could prolong the contact time of a drug with the 
applied membranes in case of topical and transdermal applications [18]. Niosomes have many 
advantages over liposomes such as the lower cost, the greater chemical stability, and the ease 
of preparation and storage. Theoretically, a niosome formulation requires the presence of a 
particular class of nonionic amphiphiles dispersed in aqueous vehicle. Cholesterol as well as 
Figure 2. Different procedures of proforms preparation. (A) Slurry method, (B) spray drying method, and (C) coacervation 
phase separation method.
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fatty alcohols (e.g., myristyl, lauryl, cetyl, steryl, and cetosteryl alcohols) are added in order to 
prepare vesicles, which are more stable and less leaky [19]. Many investigators had reported 
a decrease in drug permeability across niosomal membranes as cholesterol concentration 
increased in the bilayers of niosomal vesicles [20]. In addition, stabilizers to enhance physical 
stability of niosomal dispersions might be included in formulations of niosomes to inhibit 
aggregation of vesicles by steric, electrostatic, or repulsive effects. Often a charged surfactant 
is included in the niosomal bilayers to create electrostatic charges, hence, repulsion between 
vesicles, thereby increasing their physical stability. The addition of dicetyl phosphate (nega‐
tively charging agent) or stearyl amine (positively charging agent) to the bilayers prevents 
the aggregation of the vesicles [21]. Stability of the niosomal vesicles can also be improved by 
using a substance (e.g., poly‐24‐oxyethylene cholesteryl ether (solulan C24)) providing steric 
barrier on the vesicle surface, which can prevent vesicles aggregation [22].
An increasing number of nonionic surfactants have been found to form niosomes for the 
encapsulation of hydrophobic and/or hydrophilic solutes [23]. The nonionic surfactants for 
preparing niosomal vesicles are usually single‐alkyl chain surfactant and/or sorbitan esters. 
There are many examples belonging to different classes of nonionic surfactants that could 
be used in niosomes production such as crown ethers, glucosyldialkylether, polyglycerol 
alkylethers, and polyoxyethylene alkyl esters and ethers. These nonionic surfactant vesicles 
are prepared in the same way like liposomes and under different conditions give rise to 
either unilamellar type vesicles or multilamellar vesicles according to the method of pro‐
duction [24].
Proliposomes, proniosomes were introduced as free flowing powder and as liquid crystal‐
line preparations for reconstitution just before use [13, 25]. Proniosomes are alternatives to 
proliposomes and are important from technical view point as they possess greater chemical 
stability and do not require special preparation or storage conditions as vacuum or nitrogen 
atmosphere (Figure 2).
2.2.2. Transfersomes
Transfersomes “the carrying bodies” are designed lipid vesicles especially for transdermal 
and/or topical delivery of wide variety of drug molecules. They offer an excellent approach 
for topical drug application especially the topical immunization. Transfersomes are analo‐
gous to liposomes vesicles but contain detergent “the edge activator” in their bilayers compo‐
sition (Figure 1). They are called the ultradeformable carrier systems because they have high 
capacity of changing their shape via deformation and reformation mechanism, and passing 
through the natural pores in the stratum corneum (SC) (Figures 1 and 3). They can penetrate 
into the skin deeply and even reach the blood circulation. Transfersomes “the ultradeformable 
vesicles” containing reasonable amounts of detergent “the edge activator” did not produce 
lyses of human RBCs. They are very effective in transferring the bioactive drug molecules 
across the SC. They have the ability to penetrate through small pores “having a diameter of 
fivefold lower than their own diameter” present in the skin membrane. This indicates that a 
transfersome vesicle of diameter equaling 500 nm can pass across a membrane pore of 100 nm 
diameter or more.
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3. Formulation of gels containing lipid vesicles
For the preparation of gels containing liposomes, transferesomes or niosomes, a portion of the 
buffer required to form polymer hydrogels will be replaced by concentrated lipid vesicle dis‐
persions loaded with the drug. The gels will be prepared by sprinkling the required amount 
of gelling agent gradually over the surface of that buffer containing the drug/lipid vesicles 
and mixed until homogenous gel was obtained [26–27].
3.1. The proposed mechanisms of enhancement of drug permeability using lipid vesicles
Several mechanisms have been proposed in order to explain the enhancement of the drug 
permeability across the skin membranes using lipid vesicles. El Maghraby et al. had fully 
described these mechanisms and here we will give short account on it [28].The possible 
mechanisms for drug and/or vesicular transport through the tough skin layers are shown in 
Figure 4.
1. Free drug mechanism: The mechanism concluded that the drug permeates the skin inde‐
pendently after releasing from the vesicles. Thus, the amount of drug that permeated the 
skin could be due to its own physicochemical properties and not due to the lipid vesicle 
composition. Many researchers do not support this mechanism as the vast majority rec‐
ommended the effect of vesicles size and composition on the overall amount of the drug 
transport [28].
2. Mechanism of penetration enhancing effects: It was proven that surface‐active agents, 
which are the backbone of the formulated lipid vesicles, could enhance the transdermal 
Figure 3. A schematic representation of an ultradeformable, mixed lipid vesicle (transfersome) penetrating a narrow 
pore. Adapted from Kumar, et al [111].
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delivery of drugs by lowering the permeability barrier of the skin and interacting with the 
SC in vitro [29]. On the other hand, studies also reported that for the drug molecules to be 
effectively transported across the SC, they must be entrapped within the lipid vesicles, 
suggesting that the vesicles are not considered as penetration enhancers, but they act as 
drug carrier systems [1].
3. Fusion with the SC and/or vesicle adsorption to cells of SC: The cells of SC may fuse 
and mix with lipid vesicles increasing drug partitioning into the skin. Otherwise, the lipid 
vesicles may adhere to the SC surface via adsorption mechanism and subsequently, drug 
partition inside the SC cells could happen. Thus, lipid vesicles could fuse with SC where 
they dissolve and unite with the membrane structure [30].
4. Intact vesicular penetration mechanism into the skin: Studies on liposomes based on 
electron micrography showed intact liposomal vesicles deep in the dermis. In these stud‐
ies, the authors postulated that liposomal drug carriers could penetrate the epidermis. In 
addition, it was shown that vesicles can penetrate a ruptured or diseased SC as in case of 
eczema but cannot transport a skin with psoriasis or hyperkeratosis conditions [31]. On 
the other hand, Zellmer et al. [32], and Korting et al. [33] indicated that there was no evi‐
dence of intact liposomal carrier penetration after skin application of liposomes made from 
DMPC “1,2‐dimyristoyl‐sn‐glycero‐3‐phosphocholine” or soy‐lecithin.
5. Mechanism of transfersome transport through the stratum corneum: Transfersomes are 
of high surface hydrophilicity which respond to the hydration gradient across dermal tis‐
sue. They propel the vesicles through the transcutaneous channels giving transfersome 
vesicles the chance to act as noninvasive drug carriers. This is due to the fact that transfer‐
some vesicles are of high bilayer membrane flexibility and sufficient skin permeability 
Figure 4. Possible mechanisms of action of liposomes as skin drug delivery systems. (A) It is the free drug mechanism, 
(B) it is the penetration enhancing process of liposome components, (C) it indicates vesicle adsorption to and/or fusion 
with the stratum corneum (SC), (D) it illustrates intact vesicle penetration into or into and through the intact skin (not 
to scale), and (E) Illustrates the penetration of the vesicles through hair follicle. Adapted from El Maghraby et al. [78].
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where the trans‐barrier gradient acts on all skin membrane ingredients simultaneously but 
not to the same extent. As a result, the membrane changes its local composition under the 
influence of an anisotropic local (dehydration/hydration) stress, thus acting as a responsi‐
ble, and smart material. The transfersomal vesicle thus deforms and passes through pores 
much smaller than the average vesicle diameter spontaneously in a self‐regulated manner 
[34]. Then the hydrostatic pressure difference is responsible for the penetration of intact 
transfersome vesicles across the SC, i.e., the penetration of ultradeformable vesicles is a 
result of hydrotaxis and the permeation is governed by principles of elastomechanics [35].
6. The process of noninvasive transport across the skin consequently involves:
1. Reversible vesicle mediated opening between epidermal cells and/or lipids “intercellular 
hydrophilic pathways”.
2. Strong response of transfersome vesicles “applied transdermally” to skin hydration gradi‐
ent which is naturally occurring or an external transdermal electrical gradient.
4. Applications of hydrogels without and with lipid carriers for 
transdermal delivery of drugs
The different pharmaceutical applications of hydrogels, nanocarriers and their potential com‐
binations are summarized in Tables 1 and 2.
4.1. Hydrogels for transdermal delivery of drugs
Application of formulation on skin surface is generally meant for the topical use of derma‐
tological drugs for skin diseases. In this context, hydrogels have been widely studied for 
topical delivery of drug moieties. Several antifungal and antiinflammatory agents have been 
successfully formulated into hydrogel products using different polymers [36, 37]. Recently, 
adhesive hydrogel patches were fabricated, using sodium polyacrylate and carboxymethyl 
cellulose, for the topical delivery of triclosan in treating acne. In vitro permeation studies 
using hairless mouse skin revealed that a greater amount of drug has been transported into 
the skin layers [38].
Another application of hydrogel is its usefulness in treating wounds due to burn. The heal‐
ing rate of these types of wounds is more rapid in a moist environment as compared to the 
dry technique. Thus, the biocompatible hydrogel polymers are likely to provide moist and 
healing environment in addition to its potential to protect the wound from bacterial infec‐
tion. Moreover, these hydrogels could promote fibroblast proliferation and compensate 
fluid loss from body due to wound exudation. The hydrogels also allow greater entrap‐
ment of drug and provide controlled release, which favor rapid healing. Several hydro‐
gel based formulations have demonstrated their potential in healing the skin wounds. 
Chitosan hydrogels have been widely used in wound healing applications, where they are 
not only a vehicle but also a medicament [39]. The ideal characteristics such as hemostasis, 
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Polymer Type Drug Membrane 
/animal
Formulation 
type
Inference References
Agarose Natural Alfuzoisn Sprague‐ 
Dawley rats
Hydrogel 
patch
Prototype transdermal 
patch prepared with 
agarose successfully 
delivered alfuzosin in 
rats using iontophoresis
[68]
Chitosan Natural Berberine Wistar rat skin Hydrogel Increased the permeation  
and skin deposition in 
presence of enhancers
[45]
Liodocaine Human Hydrogel Combination of chitosan 
membrane and chitosan 
hydrogel is a good 
transparent system for 
controlled drug delivery
[49]
Diltiazem Albino rats Matrix/
membrane
Prolonged steady 
state drug plasma 
concentration was 
observed in membrane 
permeation controlled 
system
[46]
Propranolol Porcine skin Hydrogel Chitosan‐laurate and 
chitosan‐myristate 
hydrogels enhanced the 
drug diffusion through 
the skin
[48]
Dextran Natural Vitamin E Rabbit skin Hydrogel Enhance the deposition 
in the skin and increase 
the stability
[50]
HEC/HPC Natural Prochlorperazine DDY mice Hydrogel Pharmacodynamic 
activity shows the strong 
inhibitory effects after 
4 h of application and 
extended over a period 
of time
[52]
Pectin Natural Chloroquine Sprague‐ 
Dawley rat
Matrix  
patch
Plasma concentration 
of chlorquine by 
transdermal delivery 
was comparable to IV 
infusion
[51]
Poloxamer Synthetic Insulin Sprague‐ 
Dawley rats
Hydrogel Poloxamer hydrogels 
system could be used 
for the transdermal 
iontophoretic delivery of 
insulin
[119]
Capsaicin Wistar rats Hydrogel Significant enhancement 
in capsaicin 
delivery and greater 
pharmacodynamic effect 
by hydrogels compared 
to cream
[66]
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bacteriostasis, biocompatibility, biodegradability, etc. have made hydrogels an excellent 
material for wound dressing. Polyvinyl pyrrolidone‐based hydrogels were also developed 
and employed for the successful application of honey in wound treatment, which exhibited 
greater healing compared with silver sulphadiazine cream [40]. This hydrogel is also uti‐
lized in the application of iodine [41]. Hydrogels of alginate, cellulose, and poloxamer were 
also used in the treatment of wounds [42–44].
The transdermal route is considered a promising path for delivery of molecules into the sys‐
temic circulation. This route overcomes major limitations of oral therapy and provides steady 
state drug delivery. In this context, hydrogels have played an integral role in the progress of 
Polymer Type Drug Membrane 
/animal
Formulation 
type
Inference References
Polyvinyl  
alcohol
Synthetic Captopril Wistar rat Hydrogel Transdermal delivery 
of captopril is 
significantly improved by 
iontophoresis
[69]
Testosterone Sprague‐ 
Dawley rats
Hydrogel Controlled transdermal 
delivery systems can 
be developed using 
polyvinyl alcohol
[57]
Polyacrylamide Synthetic Salicylic acid Hairless pig 
skin
Hydrogel The diffusion of salicylic 
acid from the hydrogel 
is influenced by the 
cross‐linking density, 
and applied electric field 
strength
[70]
pHEMA Synthetic Theophylline Human Hydrogel 
disc
Single application 
of the hydrogel disc 
provides therapeutically 
effective concentration of 
theophylline in 24 h and 
is maintained for days
[53]
Polyacrylamide, 
pHEMA,  
carbopol 934
Synthetic Peptides Hairless rat skin Hydrogel Permeability coefficient 
decreases with increase 
in molecular weight
[71]
PVP, HPC Synthetic Nalbuphine Hairless mice Hydrogel Iontophoresis 
significantly increased 
the permeation 
nalbuphine from the 
formulated hydrogels
[72]
Alginate‐
Pluronic F127 
composite
Semi 
synthetic
Selegiline Porcine skin 
and nude 
mouse skin
Hydrogel Linear permeation profile 
observed suggests the 
successful transdermal 
delivery of selegiline
[67]
Abbreviations: HEC, hydroxyethyl cellulose; HPC, hydroxypropyl cellulose; pHEMA, poly(2‐hydroxyethyl methacrylate); 
PVP, poly vinyl pyrrolidone.
Table 1. Particulars of selected transdermal permeation studies carried out using hydrogels.
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Formulation Drugs Model used Major outcome References
Chitosan hydrogel Berberine In vitro Treatment of Leishmaniasis [45]
In vivo
Chitosan hydrogel Diltiazem HCl Diffusion  
controlled
Systems are capable of achieving the 
effective plasma concentration for a 
prolonged period
[46]
Membrane 
controlled
Chitosan hydrogel Propranolol HCl In vitro  
permeation
Hydrogels provided more 
transcutaneous permeation of 
propranolol hydrochloride than the 
corresponding solution
[48]
Dextran hydrogels 
TTS
Vitamin E In vitro Improved Vitamin E poor stability and 
increased its topical delivery
[50]
Pectin hydrogel Chloroquine In vivo The transdermal management of malaria [51]
Acrylate hydrogel 
discs
Theophylline Clinical study 
in preterm 
infants
Therapeutic concentrations of 
theophylline were achieved and 
maintained for up to 15 days after 
repeated application of discs
[53]
Poloxamer hydrogel Piroxicam In vitro Various nonionic surfactants improved 
drug permeation across rat skin
[61]
Liposome 
suspension
Curcuminoids In vitro Increased cellular uptake and 
transdermal delivery of curcuminoids
[76]
Enhanced and prolonged cytotoxic 
effects of curcuminoids
Liposome gel Triamcinolone 
acetonide
In vitro Liposomal gel increased the 
concentration of triamcinolone acetonide 
five times higher in the epidermis and 
three times higher in the dermis, than 
application of the free drug gel
[79]
Liposome 
suspension and 
emulsion vehicle
Interferon In vivo  
antimicrobial 
activity
Liposomes were better than w/o 
emulsion for treatment of cutaneous 
Herpes in guinea pigs
[80]
Liposomes; Cream Tetracaiene Clinical study Liposomal tetracaine‐produced 
anesthesia, which lasted at least 4 h after 
1 h application under occlusion
[83]
The cream formula has no effect
Liposomal 
suspension
Miconazole nitrate In vitro Enhanced skin permeation and 
retention using liposomes compared to 
commercial cream
[85]
Liposomes 
suspension
Carboxyfluorescein In vitro Selective targeting into pilosebaceous 
units of hamster ears
[86]
Liposomes in 
chitosan/gelatin 
crosslinked with 
glutaraldehyde 
hydrogels
Calcein In vitro Controlled release [92]
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Formulation Drugs Model used Major outcome References
Liposomes in 
carbopol hydrogel 
and hydroxyethyl 
cellulose gels
Calcein and 
greseofulvin
In vitro Improved release from  
carbopol gels compared to  
hydroxyethyl cellulose gels
[93]
Liposomes in 
chitosan gel
Carboxyfluorescein In vitro Delayed release [94]
Proliposome 
monophasic system 
and PEG based 
ointment
Levonorgestrel In vitro The higher potential of proliposomal 
system for efficacious transdermal 
delivery of hydrophobic drugs compared 
to PEG ointments
[96]
In vivo
Proliposomal gel Exemestane In vivo Efficient carriers with high  
potential for the enhanced  
transdermal delivery
[97]
Niosomes, 
liposomes, and 
transferesomes
Tetanus toxoid In vivo Niosomes and liposomes showed 
weak immune response transdermally 
compared to transferesomes in albino 
rats
[99]
Proniosome gel Estradiol In vitro Encapsulation efficiency was 100% [100]
High skin permeability
Niosomes Lidocaine In vitro High flux across model lipophilic 
membrane
[16]
High flux and shorter lag time across 
mouse abdominal skin compared with 
liposomes
Niosomes in chitosan 
gel
Methotrexate Clinical study Enhanced treatment of psoriasis [101]
Niosomes in 
carbopol gel
Celecoxib In vitro Improved drug localization in deep skin 
layers and muscles
[102]
In vivo Significant reduction in rat  
paw edema compared to  
conventional carbopol gels
Niosomes and 
liposomes
Tretinoin In vitro Niosomes give higher cutaneous  
drug retention than both liposomes  
and Retin A®commercial  
formulation
[105]
Ex vivo
Proniosome in 
carbopol, CMC, and 
HPMC hydrogels
Ketorolac In vitro Enhanced drug release from niosomes 
prepared with Span 60
[106]
Improved absorption of celecoxib
Improved bioavailability
Niosomes in sodium 
alginate and CMC 
hydrogels, emulgels 
and proniosomes
Ketorolac 
tromethamine
In vitro Improved skin permeability from 
niosomal gels and emulgels
[27]
Delayed drug permeability from 
proniosomes
Enhanced antiinfalmmatory effects using 
rat paw edema model
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transdermal drug delivery. This versatile hydrogel drug delivery system has been success‐
fully utilized for the delivery of molecules into and through the skin. The use of hydrogels 
in transdermal delivery is primarily owing to their intrinsic properties such as controlled/
sustained drug release for transdermal transport, higher stability, greater percutaneous 
absorption, desired functionality, and nontoxic nature. Additional advantages such as ease 
Formulation Drugs Model used Major outcome References
Transferesomes 
“Transfersulin”
Insulin In vivo Only transfersulin produced marked 
hypoglycaemic effects in mice 
however, mixed micelles, liposomes, or 
insulin solution did not produce any 
hypoglycemic effect after transdermal 
application
[108]
Clinical study Transfersulin could be administered over 
an area of 40 cm2 or less to deliver the 
basal daily supply of insulin to a typical 
type I diabetes patient
Transfersomes Triamcinolone 
acetonide
In vivo Transfersomes of Triamcinolone‐
acetonide suppresses arachidonic 
acid‐induced skin edema longer than the 
marketed products for topical treatment
[113]
Transfersomes Hydrocortisone In vivo Therapeutic concentration lowered 
significantly to 0.1% after topical 
application to mice
[114]
Transfersomes Dexamethasone In vivo Therapeutic concentration lowered to below  
0.01% after topical application to mice
[114]
Transfersomes 
“cationic type”
DNA vaccines In vivo Induced strong humoral and cellular 
immune response after topical 
application to mice
[115]
Tranfersomes in 
carbopol hydrogel
Sertraline In vitro Enhanced release and permeability  
of poor soluble drug
[116]
In vivo No skin irritation after topical 
application to guinea pigs
Better antidepressant activity of 
transferosomal gel compared to the 
control gel
Protransfersome gel Levonorgestrel In vitro Better entrapment efficiency, better skin 
permeation and better stability compared 
to proliposomes
[117]
Proliposomal gel In vivo Eight‐fold increase in peak plasma 
concentration of levonorgestrel after 
topical application to female rats
Protransfersome gel Cisplatin In vitro Improved site‐specific and localized  
drug action in the skin
[118]
In vivo Protection against cisplatin genotoxicity 
and cytotoxicity
Table 2. Pharmaceutical application of hydrogels, nanocarriers and their combinations.
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of application, better skin compliance, skin hydration, improved drug effectiveness, conve‐
nience, compliance, safety and ease of fabrication of patch, and greater swelling have made 
them to triumph over other polymeric materials. Both passive and active delivery approaches 
have been used for the transdermal delivery of molecules by fabricating patches or gels or 
carriers using hydrogels (Table 1).
Prospective of hydrogels in the transdermal delivery of drug molecules by passive process has 
been extensively studied in the last few decades. Both natural and synthetic polymers were 
widely used in developing transdermal delivery system for passive delivery. The potential of 
chitosan in developing hydrogel‐based transdermal drug delivery systems was demonstrated 
in several investigations. Tsai et al. have successfully delivered berberine through the skin by 
incorporating in a hydrogel formulation for the treatment of leishmaniasis [45]. This polymer 
was also utilized in developing hydrogel‐based matrix diffusion controlled and membrane 
permeation controlled transdermal systems of diltiazem. The in vivo permeation studies in rat 
model signified the prospective of this polymer to deliver effective concentration of drug for 
a prolonged period of time [46]. Several studies were also reported wherein chitosan‐based 
hydrogel transdermal systems have been successfully utilized [47]. Hydrogels of this polymer 
prepared by physical crosslinking method were utilized for transdermal delivery of propran‐
olol [48]. Multiple functions of chitosan as a rate controlling membrane and as reservoir in the 
transdermal delivery system were also demonstrated [49].
Cassano et al. have developed dextran hydrogel transdermal system, which deposits greater 
amount of vitamin E in the skin and enhances the vitamin stability [50]. This transdermal 
system was prepared by adding the methacrylic groups on dextran and the product (methac‐
rylated dextran) was further copolymerized with aminoethyl methacrylate. This is then esteri‐
fied with transferulic acid to protect the vitamin E from photodegradation. Pectin, another 
polysaccharide, was also utilized in developing hydrogel matrix patch for the transdermal 
delivery of chloroquine [51]. Similarly, hydrogels of cellulose polymers (hydroxyethyl cellu‐
lose and hydroxypropyl cellulose) have also demonstrated their prospective in preparing dif‐
ferent transdermal delivery systems [52].
Acrylate polymers were also extensively studied for their potential in developing various 
transdermal systems. A hydrogel disc consisting of 90% w/w poly‐2‐hydroxyethyl methac‐
rylate, crosslinked with 10% w/w polytetramethylene oxide was used for the transdermal 
delivery of theophylline in infants (Figure 5). The repeated application of discs has delivered 
therapeutic concentrations of theophylline and maintained for a period of 2 weeks [53]. In 
another attempt, various poly(hydroxyethyl methacrylate) copolymeric hydrogels were syn‐
thesized using 2‐hydroxyethyl methacrylate, methacrylic acid and N‐[3‐(dimethylamino)pro‐
pyl] methacrylamide by redox free radical bulk polymerization technique and assessed for 
their prospective in transdermal delivery system using salbutamol sulphate [54]. Hydrogel 
prepared with different latex particles (polyacrylic acid‐co sodiumacrylate, polyacrylic acid‐
co‐2‐ethylhexyl acrylate and polyN‐isopropylacrylamide) within carboxymethyl cellulose 
matrix displayed thermosresponsive release of caffeine, signifying its potential in developing 
transdermal delivery systems [55]. There are reports wherein composite membrane of cross‐
linked poly(2‐hydroxyethyl methacrylate) has been developed and successfully employed as 
rate controlling barrier for membrane transdermal drug delivery systems [56].
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Polyvinyl alcohol‐based hydrogels were also developed and evaluated for the transdermal 
delivery of testosterone, both in vitro and in vivo. It was observed that the prepared hydrogel 
effectively delivering drug into the systemic circulation indicates the potential of this polymer 
in developing a transdermal system [57]. pH sensitive hydrogels have also been developed 
using poly‐electrolyte, poly(acrylamide: maleic acid) for the delivery of terbinafine (cationic) 
wherein drug release was influenced by pH of media [58]. Alternatively, ionic polymers 
like N vinyl‐2‐pyrrolidone and methylene succinic acid have been successfully employed in 
developing the transdermal drug delivery systems [59]. Reports also exist wherein hydrogels 
are used to fabricate transdermal patch for the delivery of vaccine [60].
Poloxamer is probably one of the most extensively studied polymers in transdermal drug 
delivery. This polymer has demonstrated its potential as a transdermal vehicle for delivery 
by passive and active approaches [61, 62]. Several molecules of different categories are suc‐
cessively delivered using this polymer. The ideal concentration for the topical application 
of this polymer was found to be ∼20% [63]. The prospective of this polymer in enhancing 
the transdermal delivery of molecules, providing controlled zero order release, prolong‐
ing therapeutic effect, delivering macromolecules was documented in the literature [64–66]. 
Composite thermogels of poloxamer were also utilized in transdermal delivery of certain 
molecules [67–72].
4.2. Liposomes for transdermal delivery of drugs
Liposomes are widely used as carriers due to the small size, both hydrophobic and hydro‐
philic properties, biodegradability, and high safety [73]. Several studies demonstrated the 
Figure 5. Hydrogel disc occluded with a transparent dressing on the abdomen of an infant of 29 weeks gestation. 
Adapted from Cartwright et al. [54].
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great potential of liposomes as lipid vehicles, which are able to enhance drug permeation 
through the skin and also can act as local depot for the drug to sustain and control its delivery 
[74, 75].
A recent investigation showed that liposomes were induced to deliver and release very poor 
water‐soluble drugs such as curcuminoids at a controlled rate to targeted cells [76]. Authors 
have evaluated and proved the contribution of liposomal curcuminoids to the antiprolifera‐
tion as well as to the apoptosis of breast cancer cell lines. Another investigation done by El 
Maghraby et al. about the effects of liposomes after topical application indicated that lipo‐
somes could exert different functions, which may be local or enhanced systemic absorption 
[77]. They can improve drug deposition into the skin at the site of action providing local 
effects and reducing systemic absorption and drug side effects. Moreover, the liposomes as 
a drug carrier can provide high potential for transdermal delivery and targeted delivery to 
skin appendages. Liposomes as lipid carriers for triamcinolone acetonide showed increased 
drug concentration in SC as well as in the dermis by fivefold compared with a standard 
ointment of the same drug [78]. In one more research by the same authors, the incorporation 
of these liposomes encapsulating triamcinolone acetonide in a gel dosage form resulted in 
nonsignificant differences in drug concentrations in SC and dermis when compared with a 
gel containing liposome components as well as the free drug at the same concentrations [79]. 
Moreover, the topical delivery of interferon (peptide drug) from liposomes was greater than 
that from emulsion form (w/o) or aqueous solution when in vivo applied to cutaneous herpes 
simplex virus guinea pig model [80]. Egbaria et al. had employed a tape striping technique 
on guinea pig skin in vitro and liposomes showed increased deposition and accumulation of 
interferon into SC and deeper stratum [81]. It has been demonstrated that liposomes with 
lipophilic drugs such as progesterone or hydrocortisone “entrapped in the bilayer structure 
of the lipid vesicles” permeate the skin like the free drug itself. Conversely, glucose (highly 
polar molecule) enclosed in the aqueous compartment of liposomal vesicle was found not 
available for transport across the skin. It was suggested that direct transfer of the drug mol‐
ecule from liposomal suspension to the skin occurs only when the drug is entrapped within 
the lipid bilayer [82]. Liposomes can also improve the local anesthetic activity of tetracaine 
and lidocaine where the cream formula has no effects [83, 84]. Ethanol containing liposomes 
(Ethosomes) enhanced the intensity and duration of benzocaine local anaesthetic effect [75]. 
The localizing effects or efficiency of liposomes was dependent on the lipid composition and 
method of preparation. In addition, the liposomal miconazole nitrate has shown to facilitate 
the localized drug delivery and improved its availability by a controlled release pattern, 
which enhanced the treatment of deep fungal infections [85]. In addition to the enhanced 
localized accumulation effects of liposomes, they can target drugs to skin appendages and 
improved transdermal delivery of drugs. Lieb et al. showed selective carboxyfluoresce in 
liposomes targeting into the pilosebaceous follicles of the hamster ears when compared with 
aqueous or alcoholic solutions containing 10% ethanol or even with 0.05% sodium lauryl 
sulphate, or propylene glycol donor vehicles [86]. Due to the highest follicular density in 
hamster skin and hairless mice skin as compared to human skin, a higher drug accumula‐
tion was observed in their skin suggesting the drug deposition from liposomes through the 
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follicular pathway [87]. This is true for hydrophilic drugs encapsulated into liposomes; how‐
ever, highly lipophilic drugs could target the sebaceous gland and no significant differences 
in drug accumulation was observed when liposomes were compared with mixed micelles or 
ethanolic gels [88].
Liposomes as nanocarriers were reported to improve transdermal delivery of drugs. Ganesan 
et al. observed that after finite dose applications of lipophilic drugs to hairless mouse skin, 
greater amounts were delivered from liposomal vesicles compared to aqueous vehicles [82]. 
In addition, vesicles of fluid liposomes produced high percutaneous absorption and tissue 
distribution rather than skin accumulation [89]. Conversely, there are some reports which 
generally excluded a liposome transport process across the skin where they attributed their 
positive influence on increased skin permeability to a localizing effect as the drugs accumu‐
lated on skin surface or the upper layers of SC, hence, favoring their diffusion. This was done 
for lipophilic drugs such as ketoprofen where the drug was first complex with cyclodextrin 
and then encapsulated into liposomes [90, 91].The major aim of inclusion of liposomes into 
a hydrogel was to control the release of drugs and to stabilize the liposomal bilayer struc‐
ture by creating a protective film on surfaces of liposomal vesicles. Ciobanu et al. had for‐
mulated chitosan/gelatin hydrogel by double crosslinking with glutaraldehyde and sodium 
sulphate/sodium tripolyphosphate to be used as matrices for the inclusion of calcein loaded 
liposomes [92]. Calcein, a model hydrophilic drug in small unilamellar vesicles (SUVs) and 
multilamellar vesicles (MLVs), was released from polymeric hydrogels for several days to 
weeks. In another study, liposomes prepared from phosphatidylcholine (PC) or distearoyl‐
glycero‐PC and cholesterol (DSPC/Chol), and incorporating calcein or greseofulvin were for‐
mulated by thin film hydration technique. Calcein and greseofulvin release from liposomal 
gels using carbopol polymer was faster compared to hydroxyethyl cellulose and mixture 
gels [93]. Billard et al. prepared an innovative hybrid formulation, which was composed of 
a water‐soluble model molecule “carboxyfluorescein” in liposomal vesicles and dispersed 
in tridimensional matrix of chitosan hydrogel [94]. Liposome dispersions in chitosan gel in 
water did not affect the gelation process absolutely. The release of carboxyfluorescein was 
delayed from the hybrid liposomes in hydrogel systems compared to the hydrogel matrix 
without lipid vesicles.
Taking into consideration the potential use of proliposomes for transdermal delivery of drugs, 
topical application of nicotine‐loaded proliposomes under occlusive conditions was evident 
to sustain nicotine delivery across the skin [95]. In addition, Deo et al. had proven that the 
system proliposomes was superior to PEG‐based ointment for the transdermal delivery of 
levonorgestrel (model hydrophobic drug) [96]. Moreover, proliposomal gels prepared and 
evaluated for transdermal bioavailability of exemestane (a novel steroidal aromatase inacti‐
vator used in the treatment of advanced breast cancer) were compared with control oral sus‐
pension of the drug [97]. Proliposomal gels offered high potential and was efficient carriers 
for the enhanced sustained transdermal delivery of Exemestane. Proliposomal gel showed 
greater percentage of inhibition of edema when compared to marketed diclofenac gel in the 
treatment of rheumatoid arthritis. They also exhibited superior stability when compared to 
traditional liposomes, thereby increasing its potential application in transdermal delivery 
systems [98].
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4.3. Niosomes for transdermal delivery of drugs
One of the most useful advantages of niosomes is that they greatly enhance the uptake of 
drugs via transdermal route. Transdermal drug delivery using niosomes is widely used in 
cosmetics. Niosome‐entrapped antibiotics were successfully used to treat acne. The pen‐
etration of drugs into the skin was greatly enhanced as compared to unentrapped drug. 
The noninvasive transdermal vaccination via topical application of niosomes is also being 
researched. Gupta et al. has shown that niosomes of tetanus toxoid (along with liposomes 
and transfersomes) can be used for transdermal immunization [99]. However, the current 
results of niosomal topical immunization allow only a weak immune response, and thus 
more research needs to be done in this field. The encapsulation efficiency of estradiol in 
proniosomes made from Span 40, Span 60 was 100%, and the permeability of the drug across 
the nude mouse skin was high as reported by Fang et al. [100]. Lidocaine and lidocaine 
hydrochloride loaded nonionic surfactant vesicles were formulated using Tween 20 and 
cholesterol, and tested for their local anesthetic effects [16]. The diffusion experiments indi‐
cated high flux of charged lidocaine (lidocaine hydrochloride) through a model lipophilic 
(Silastic™) membrane and found to be possible only after vesicle formation. In addition, the 
permeation of the drug from niosomes through mouse abdominal skin showed higher flux 
and shorter lag times compared with liposome formulations. Methotrexate‐loaded niosomal 
vesicles in chitosan gel were used in the treatment of psoriasis by double blind, placebo con‐
trolled study on healthy human volunteers and psoriasis patients [101]. Kaur et al. showed 
6.5 times higher drug deposition in deep skin layers and muscles from celecoxib niosomal 
gels compared with carbopol gel indicating better drug localization with niosomal gel [102]. 
In the same study, a significant reduction of rat paw edema was resulted after adminis‐
tration of niosomal formulation compared to that of applying conventional gel. Psoriasis 
area severity index (PASI) was the measure for the severity of the disease. The reduction in 
PASI scores after 12 weeks of niosomal methotrexate gel topical application was found to be 
threefold with better clinical efficacy, tolerability and patient compliance. Niosomes were 
also included in the treatment of vitiligo. Elastic cationic niosomes composed of tween 61/
cholesterol/dimethyl dioctadecyl ammonium bromide at 1:1:0.5 molar ratio were effectively 
used for the dermal delivery of tyrosinase encoding plasmid. Their percutaneous absorption 
across exercised rat skin showed greater flux compared with the nonelastic niosomes. The 
application of pMEL34‐loaded elastic cationic niosomes in melanoma cell lines gave four 
times increase in tyrosinase gene expression compared with the free and the plasmid in non‐
elastic niosomes which lead to efficient topical delivery in vitiligo therapy [103]. Tretinoin 
(vitamin A metabolite), is topically applied for the treatment of skin diseases such as acne, 
psoriasis, and photoaging. The drug has high chemical instability and skin irritation, which 
limited its topical administration [104]. However, the drug transdermal delivery using nio‐
somes and liposomes as vehicle carriers showed more upper cutaneous drug retention than 
commercial formulation “RetinA®” [105].
Ketorolac proniosomes of Span 60 and Tween 20 and mixed with carbobol, carboxymethyl 
cellulose (CMC) or hydroxypropylmethyl cellulose (HPMC) hydrogels were evaluated by 
Alsarra et al. [106]. They found that the drug release was higher from niosomes prepared 
with Span 60 than from the HPMC gel as control due to the formation of elution channels 
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and loss of vesicular structure. However, authors did not give any scientific reason for that 
explanation. Conversely, Mokhtar and Shehata showed the formation of greater vesicles 
after niosome/hydrogel admixture and explained this by the vesicles crack and reformation 
during the preparation procedure, which improved ketorolac tromethamine leakage to the 
outside vehicle (Figure 6) [27]. A recent study indicated that no percutaneous permeation 
Figure 6. Micrographs (magnification power is 40×) of alginate gel (A), emulgel (B), niosomal gel (C), niosomalemulgel 
(D), proniosomes (E) and niosomes suspension (F). Adapted from Mokhtar and Shehata, its first publication in J Drug 
Del Sci Tech. With copywriter permission [27].
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was achieved when using submicellar solution of pluronic and sucrose esters containing free 
Sulfadiazine sodium or when the skin was pretreated with blank niosomes or submicellar 
solutions of the surfactant free of the drug and only the drug niosomal vesicles can do enhanc‐
ing the skin permeability [107].
4.4. Transfersomes for transdermal delivery of drugs
The use of transfersomes technology is an innovative approach to increase the transport of sub‐
stances through the skin. Nonocclusive administration of drug moieties using transfersomes 
is useful for noninvasive drug delivery of therapeutic proteins transdermally. Transdermal 
administration of diverse molecules with ultradeformable vesicles also permits targeted skin 
delivery or preferential delivery into the deep tissue of the dermis under the site of application.
Transferesomes have high suspension‐driving pressures, which can eliminate the mismatch 
effect of carrier and pore size. This can be considered true for the transfersomes with a size not 
more than threefold the size of transdermal pores. The transcutaneous glands or hair follicles 
are well known to play a role in the process of molecular diffusion across the skin. However, 
such channels are too impermeable to large molecule such as insulin transdermally [108]. 
This could explain why a topically applied insulin in the mixed‐lipid micelles or liposomes 
had nonsignificant antidiabetic effects. Transfersomes have a higher flexibility and stability 
than liposomes which allows them to penetrate through the human skin. The incorporation 
of insulin molecules into the vesicle of these lipid particles (transfersulin) results in a con‐
siderable insulin transport through the skin into the blood stream in mice and to a lower 
extent in humans [108]. Moreover, transfersomes can deliver an antigen to the lymphatics 
from where they can be transferred to lymph nodes. The antigens are then phagocytosed and 
presented to the T‐cells in the lymph nodes. Thus, transfersomes are very important carriers 
for transdermal delivery of antigens and are under investigation for use in human vaccina‐
tion development [109–110]. The transdermal enhancement of drug permeability using these 
ultradeformable vesicles does not depend upon the concentration gradient and mainly work 
on the principle of hydrotaxis and elastomechanics as reported by Kumar et al. [110].
The transfersomes deform and reform but remain intact during the transportation of the 
loaded drug to the target tissues under the skin application site. These carriers which are 
driven by the local water gradient across the skin barrier could be engineered to achieve 
a localized and high drug concentration at the application sites and deep inside the der‐
mis. This way of drug administration can abolish any local and/or systemic adverse drug 
effects, and often increase the drug potency. Also, the local clearance through the cutane‐
ous microcirculation is avoided, which permits the drug delivery deep into the muscles or 
joints. Therefore, transfersomes greatly increase the ratio of drug concentration in the tar‐
get tissue more than the systemic drug concentration when compared to other formulations 
“liposomes or niosomes of the drug”, which inherently enhances the drug safety profiles. In 
addition, the transfersomes could be targeted to the macrophages if suitably designed, thus, 
they have sufficient immune‐adjuvant action. After topical application of transfersomes, they 
showed comparable titer values with their intradermal counterparts; however, they required 
lesser dosages [109]. Transfersomes encapsulating bacterial gap junction proteins gave rise 
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to circulatory antibodies against the gap junction proteins when applied topically. It was 
interesting that the antibodies titer value was found to be greater than that produced after 
subcutaneous injection of the gap junction proteins [111].
The study done by Kim et al. has vividly shown that the ultradeformable cationic vesicle (cat‐
ionic transfersomes) formulation has several characteristics of being a good nonviral vector 
system, for instance, high transfection activity and long retention time [112]. This formulation 
was prepared using a cationic lipid, 1,2‐dioleoyl‐3‐trimethyl‐ ammonium propane chloride 
(DOTAP) and sodium cholate, and it was found to be capable of transfecting several cell lines 
as well as penetrating the intact skin of mice when transdermally applied. In addition, this 
formulation is found to be stable and has shown 6 days of gene expression, an essential factor 
for an efficient gene therapy. Therefore, it is developed further as either invasive or noninva‐
sive gene delivery system.
Topical usage of triamcinolone acetonide with ultradeformable vesicles resulted in reduction of 
the necessary drug dose to the levels of 0.01 wt% (10‐fold lower drug dosage compared to cream 
or lotion preparations). Epicutaneous drug administration of these highly deformable carriers 
was also observed to prolong the biological response time markedly and to increase the repro‐
ducibility of the biological drug action [113]. In another study done by Cevc and Blume, either 
hydrocortisone or dexamethasone formulations in a suspension of very deformable vesicles 
(transfersomes) have significantly lowered the therapeutically relevant concentration range to 
0.1 wt% and may be lower than 0.01 wt%, respectively [114]. This is lower than the respective 
concentrations used in commercial hydrocortisone and dexamethasone products “0.25–2.5 wt% 
(mainly 1%) and 0.03–0.1 wt%, respectively”. The biological response time for the local cortico‐
steroid action was prolonged and the sensitivity of dexamethasone in very deformable vesicles 
to abrasion was diminished. These findings confirmed the expectation that very deformable car‐
riers offer several advantages for transdermal delivery of corticosteroids into the skin. Cationic 
transfersomes were formulated and tested for topical immunization using cationic transfer‐
somes based DNA vaccine. They were capable of inducing strong humoral and cellular immune 
response and offered all the advantages of DNA vaccines, and overcome the disadvantages of 
classical invasive methods of vaccination [115]. Transfersomal gels prepared by Gupta et al. using 
Span 80, soya lecithin, and carbopol was found to enhance skin delivery of sertraline (antidepres‐
sant drug) due to excellent release and permeation of the drug [116]. They found no skin irritation 
after transdermal application of the gel formulation containing transfersomes. Since a properly 
designed ultradeformable vesicles could even claim the transport of drug (of different sizes, even 
large peptide or DNA) equivalent to the subcutaneous injection and this technology may provide 
effective tool for noninvasive therapy. The enhanced transdermal delivery of bioactive molecules 
by transferesomes also opens new challenges for the development of novel therapies.
Protransfersomal gels of levonorgestrel were developed for transdermal contraceptive use 
[117]. Authors indicated that the protransfersomal gels possessed better stability, better skin 
permeability, and greater encapsulation efficiency than proliposomal formulation. Recently, 
protransfersome showed better noninvasive delivery of cisplatin in cutaneous squamous 
cell carcinoma [118]. They have improved site‐specific and localized drug action in the skin; 
hence, they provide a better option for dealing with serious diseases of skin such as squamous 
cell carcinoma. In addition, they had high potential as topical drug delivery system with pro‐
tection against genotoxicity and cytotoxicity of cisplatin.
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5. Conclusion
This review article provides valuable information regarding the hydrogels, emulgels and 
their combination with lipid nanocarriers “liposomes, niosomes and transferesomes” for 
topical and transdermal drug delivery. It has been shown that all of these systems have great 
potentials, being able to deliver both lipophilic and/or hydrophilic active ingredient via trans‐
dermal route of administration. The inclusion of lipid vesicles into hydrogels could enhance 
their stability, prolong drug release, enhance transdermal permeability, and increase localiza‐
tion of the drug in the skin. Proforms of the lipid vesicles could also improve site‐specific and 
localized drug action in the skin. In order to optimize these drug delivery vehicles, a greater 
understanding of polymer and biological interaction mechanisms is required. Hydrogel com‐
binations with lipid nanocarriers could be of great potential for increasing transdermal drug 
delivery and clinical research in the future.
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